Spada, F.
Pellicori, S.
Zampino, G.
Funicelli, L.
Gervaso, L.
Laffi, A.
Rubino, M.
Garcia-Carbonero, R.
Fazio, N. http://orcid.org/0000-0001-6869-0704
Article History
Received: 30 April 2020
Accepted: 6 July 2020
First Online: 17 July 2020
Compliance with ethical standards
:
: F.S. is the principal investigator of the phase II/III international randomized double-blind study (ClinicalTrials.gov Identifier: NCT01744249) at the IEO (Milan) centre. A.L., M.R., and N.F. are coinvestigators of the phase II/III international randomized double-blind study (ClinicalTrials.gov Identifier: NCT01744249) at the IEO (Milan) centre. R.G.-C. is the global principal investigator of the phase II/III international randomized double-blind study (ClinicalTrials.gov Identifier: NCT01744249). The other authors declare that they have not conflict of interest.
: The patient gave the consent to the publication.
Free to read: This content has been made available to all.